Alector (ALEC) Non-Current Assets (2018 - 2026)
Alector (ALEC) posted quarterly Non-Current Assets of $24.8 million for Q1 2026, down 40.38% year-over-year from $41.7 million in Q1 2025, and down 7.29% quarter-over-quarter from $26.8 million in Q4 2025.
Alector (ALEC) Non-Current Assets (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Non-Current Assets for 9 consecutive years, with $24.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Non-Current Assets fell 40.38% year-over-year to $24.8 million; the TTM figure through Mar 2026 stood at $123.8 million (down 32.31% YoY), while the FY2025 annual figure was $26.8 million, down 38.41% from the prior year.
- Non-Current Assets eased to $24.8 million in Q1 2026 per ALEC's latest filing, from $26.8 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $63.5 million in Q1 2022 and bottomed at $24.8 million in Q1 2026.
- Historically, Non-Current Assets has averaged $49.9 million across 5 years, with a median of $54.1 million in 2024.
- Annual changes were most pronounced in 2023 — Non-Current Assets fell 1.87% — and 2026, when it plunged 40.38%.
- Alector's Non-Current Assets stood at $61.2 million in 2022, then retreated by 8.48% to $56.0 million in 2023, then dropped by 22.37% to $43.5 million in 2024, then sank by 38.41% to $26.8 million in 2025, then dropped by 7.29% to $24.8 million in 2026.
- Business Quant data shows ALEC's Non-Current Assets at $24.8 million in Q1 2026, $26.8 million in Q4 2025, and $34.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 14.88 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 23.28 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.96 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 294.93 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.96 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.76 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 18.06 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 938.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 468.65 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 22.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.77 Mn |
| Mar 31, 2026 | 24.83 Mn |
| Dec 31, 2025 | 26.79 Mn |
| Sep 30, 2025 | 34.90 Mn |
| Jun 30, 2025 | 37.24 Mn |
| Mar 31, 2025 | 41.65 Mn |
| Dec 31, 2024 | 43.49 Mn |
| Sep 30, 2024 | 46.66 Mn |
| Jun 30, 2024 | 51.03 Mn |
| Mar 31, 2024 | 54.10 Mn |
| Dec 31, 2023 | 56.02 Mn |
| Sep 30, 2023 | 59.25 Mn |
| Jun 30, 2023 | 60.75 Mn |
| Mar 31, 2023 | 62.34 Mn |
| Dec 31, 2022 | 61.21 Mn |
| Sep 30, 2022 | 62.08 Mn |
| Jun 30, 2022 | 62.65 Mn |
| Mar 31, 2022 | 63.53 Mn |
| Dec 31, 2021 | 64.95 Mn |
| Sep 30, 2021 | 66.21 Mn |